Simon MA , Iordanov I , Szollosi A , Csanády L .

739593 EU Horizon 2020 Research and Innovation Program, CSANAD21G0 Cystic Fibrosis Foundation, KKP 144199 National Research, Development and Innovation Office, ÚNKP-22-3-II-SE-12 Ministry for Innovation and Technology of Hungary, ÚNKP-22-3-II-SE-12 Ministry for Innovation and Technology

             ABC-type sodium transporter activity

	Figure 1 CFTR topology and gating cycle. (A) Cartoon topology of CFTR. TMD1–2, gray; NBD1, blue; NBD2, green; R-domain, pale red. Red asterisk denotes catalytic site mutations. (B) Cartoon of head-to-tail NBD dimer. Color coding as in (A). ATP, large yellow circles. Site 2 (top): conserved Walker A/B residues, small red circles; catalytic base, small black circle; signature sequence, magenta crescent. Site 1 (bottom): color coding as for site 2, pale residues represent non-conserved substitutions. Residue numbering corresponds to the human CFTR sequence. (C) Schematic gating cycle of phosphorylated CFTR. Flickery closures from states B1 and B2 are not depicted. Disruption of ATP hydrolysis in catalytic site mutants (red cross) reduces gating to reversible IB1 ↔ B1 transitions (red box). Note, that in reality sites 1 and 2 are equally near the membrane, in the cartoons site 2 is depicted as the top and site 1 as the bottom site merely for representation purposes.
	Figure 2 Non-native inter-NBD H-bond in OF E-to-Q mutant hCFTR, but not zCFTR, suggested by cryo-EM structures. (A) Macroscopic current relaxations upon ATP removal in inside-out patches excised from Xenopus laevis oocytes expressing hE1371Q (black trace), hE1371S (dark blue trace), zE1372Q (brown trace), and zE1372S (light blue trace) CFTR channels. Currents were activated by exposure to saturating ATP, following prior phosphorylation for ~2 min with 300 nM bovine PKA catalytic subunit. Current amplitudes are shown normalized by their steady-state values in ATP (i.e., just before ATP removal), membrane potential (Vm) was −20 to −80 mV. (B) Mean burst durations (in seconds) obtained as the time constants of single-exponential fits to the macroscopic relaxations shown in (A). Data are shown as mean ± standard error of the mean (SEM) from six to nine experiments using a logarithmic ordinate. (A, B) has been adapted from Figures 2A, B, and 3C, D from Simon and Csanády, 2023. (C, D) Cryo-EM structures of hCFTR-E1371Q (PDBID: 6msm) and zCFTR-E1372Q (PDBID: 5w81) in the OF conformation. Color coding as in (A), positions hG576/zT575 (orange), hQ1371 (black), and zQ1372 (brown) are shown in spacefill. Red dotted squares identify regions expanded in panels (E, F). (E, F) Close-up views of the regions surrounding the mutated catalytic glutamate side chains (black/brown sticks) in OF hCFTR (E) and zCFTR (F).
	Figure 3 Strong coupling between positions 576 and 1371 of hCFTR E1371Q in the bursting state. (A) Macroscopic current relaxations following ATP removal for indicated human CFTR channel mutants (color coded). Inside-out patch currents were activated by exposure of pre-phosphorylated channels to saturating ATP. Current amplitudes are shown normalized by their steady-state values in ATP (i.e., just before ATP removal). Vm was −20 to −80 mV. (B) Relaxation time constants of the currents in (A), obtained by fits to single exponentials. Data are shown as mean ± standard error of the mean (SEM) from seven to nine experiments using a logarithmic ordinate. (C) Thermodynamic mutant cycle showing mutation-induced changes in the height of the free enthalpy barrier for the B1 → IB1 transition (ΔΔG0T‡−B1, numbers on arrows; k, Boltzmann’s constant; T, absolute temperature). Each corner is represented by the mutations introduced into positions Q1371 and G576 of E1371Q-hCFTR. ΔΔGint(B1 → T‡) (purple number) is obtained as the difference between ΔΔG0T‡−B1 values along two parallel sides of the cycle. (D) Currents of last open channels after ATP removal for the indicated human CFTR constructs (color coded). Recordings were done as in panel (A), but on patches with smaller numbers of channels. Membrane potential was −80 mV. Black lines indicate the analyzed segments. (E) Intraburst equilibrium constants obtained by dwell-time analysis for the four human CFTR constructs, plotted on a logarithmic scale. Data are shown as mean ± standard error of the mean (SEM) from five to six experiments. (F) Thermodynamic mutant cycle showing mutation-induced changes in the stability of the O state relative to the Cf state (ΔΔG0O-CF, numbers on arrows; k, Boltzmann’s constant; T, absolute temperature). Each corner of the cycle is represented by the mutations introduced into positions Q1371 and G576 of E1371Q-hCFTR. ΔΔGint(Cf → O) (purple number) is obtained as the difference between ΔΔG0O-CF values along two parallel sides of the cycle.
	Figure 4 No coupling between positions 575/576 and 1372 of zCFTR E1372Q in the bursting state. (A, D) Macroscopic current relaxations following ATP removal for indicated zCFTR channel mutants (color coded). Experiments were performed as in Figure 3A, and current amplitudes are shown normalized by their steady-state values in ATP (i.e., just before ATP removal). (B, E) Relaxation time constants of the currents in (A, D), obtained by fits to single exponentials. Data are shown as mean ± standard error of the mean (SEM) from 6 to 10 experiments using a logarithmic ordinate. (C, F) Thermodynamic mutant cycles showing mutation-induced changes in the height of the free enthalpy barrier for the B1 → IB1 transition (ΔΔG0T‡−B1, numbers on arrows; k, Boltzmann’s constant; T, absolute temperature). Each corner is represented by the mutations introduced into positions Q1372 and either T575 (C) or H576 (F) of E1372Q-zCFTR. ΔΔGint(B1 → T‡) (purple number) is obtained as the difference between ΔΔG0T‡−B1 values along two parallel sides of the cycle.
	Figure 5 Mutation hE1371Q strongly stabilizes, whereas hD1370N destabilizes, bursts in other non-hydrolytic backgrounds. (A) Close-up view of the site 2 interface in the OF structure of hCFTR-E1371Q (PDBID: 6msm) highlighting (in sticks) NBD1 D-loop residue hG576 (orange), and NBD2 residues hQ1371 (black), hD1370 (gray), and hK1250 (gray). ATP, yellow sticks; Mg2+, purple sphere. (B, D), Macroscopic current relaxations following ATP removal for indicated CFTR channel mutants (color coded). Experiments were performed as in Figure 3A, and current amplitudes are shown normalized by their steady-state values in ATP (i.e., just before ATP removal). (C, E), Relaxation time constants of the currents in (B, D), obtained by fits to single exponentials, displayed on a logarithmic ordinate. Data show mean ± standard error of the mean (SEM) from five to eight experiments.
	Figure 6 Coupling between bursts and ATP hydrolysis in wild-type (WT) hCFTR. Quantitative hCFTR gating cycle, color coding as in Figure 1C. Numbers represent estimated microscopic rate constants for prephosphorylated WT hCFTR channels gating in ATP at 25°C, with k−1 (red) established in the present study. Cyan arrows and numbers illustrate the fractions of bursts that are terminated by ATP hydrolysis and non-hydrolytic dissociation of composite site 2, respectively.
	Figure 2—figure supplement 1 Experimental electron densities around residues G576 and Q1371 in OF structure of hCFTR E1371Q. Electron densities (gray mesh, EMD-9230) and atomic model (sticks, PDBID: 6msm) of residues hG576 and hQ1371 in OF hCFTR-E1371Q.
	Figure 4—figure supplement 1 Close-up view of the region surrounding the mutated catalytic glutamate side chain (brown sticks) and D-loop residues zT575 (orange sticks) and zH576 (magenta sticks) in the cryo-EM structure of zCFTR-E1372Q, solved in the OF conformation (PDBID: 5w81). Purple dotted line illustrates suggested H-bond between the zT575 side chain and the backbone carbonyl oxygen of zA1375 (green sticks).
	Figure 5—figure supplement 1 Intra-NBD2 movements associated with ATP binding and tight NBD dimerization. (A) Location of positions 576, 1370, and 1371 (colored spacefill) relative to composite sites 1 and 2 in the tight hCFTR NBD dimer (PDBID: 6msm). Interacting positions 555 and 1246 (Vergani et al., 2005) are also shown in colored spacefill. (B) NBD2 structures of non-phosphorylated apo IF hCFTR (6uak; light green), non-phosphorylated ATP-bound IF hCFTR (8fzq; medium green), and phosphorylated ATP-bound OF E1371Q-hCFTR (6msm; dark green), aligned through their core subdomains. ATP (shades of yellow), and Mg2+ (shades of purple) of the ATP-bound structures are shown as sticks and spheres, respectively. Note completion of subdomain closure (curved arrow) in the OF structure. (C) Atomic models (sticks and spheres) of ATP (shades of yellow), Mg2+ (shades of purple), and residues D1370 (shades of gray) and S1251 (shades of green) from ATP-bound non-phosphorylated IF WT hCFTR (lighter tones; PDBID: 8fzq) and phosphorylated ATP-bound OF E1371Q hCFTR (darker tones; PDBID: 6msm). The core subdomain of NBD2 from 6msm was aligned with that of 8fzq in Pymol. Residue h1371 (black sticks) is shown only for the OF structure.
	Figure 1. CFTR topology and gating cycle.(A) Cartoon topology of CFTR. TMD1–2, gray; NBD1, blue; NBD2, green; R-domain, pale red. Red asterisk denotes catalytic site mutations. (B) Cartoon of head-to-tail NBD dimer. Color coding as in (A). ATP, large yellow circles. Site 2 (top): conserved Walker A/B residues, small red circles; catalytic base, small black circle; signature sequence, magenta crescent. Site 1 (bottom): color coding as for site 2, pale residues represent non-conserved substitutions. Residue numbering corresponds to the human CFTR sequence. (C) Schematic gating cycle of phosphorylated CFTR. Flickery closures from states B1 and B2 are not depicted. Disruption of ATP hydrolysis in catalytic site mutants (red cross) reduces gating to reversible IB1 ↔ B1 transitions (red box). Note, that in reality sites 1 and 2 are equally near the membrane, in the cartoons site 2 is depicted as the top and site 1 as the bottom site merely for representation purposes.
	Figure 2—figure supplement 1. Experimental electron densities around residues G576 and Q1371 in OF structure of hCFTR E1371Q.Electron densities (gray mesh, EMD-9230) and atomic model (sticks, PDBID: 6msm) of residues hG576 and hQ1371 in OF hCFTR-E1371Q.
	Figure 2. Non-native inter-NBD H-bond in OF E-to-Q mutant hCFTR, but not zCFTR, suggested by cryo-EM structures.(A) Macroscopic current relaxations upon ATP removal in inside-out patches excised from Xenopus laevis oocytes expressing hE1371Q (black trace), hE1371S (dark blue trace), zE1372Q (brown trace), and zE1372S (light blue trace) CFTR channels. Currents were activated by exposure to saturating ATP, following prior phosphorylation for ~2 min with 300 nM bovine PKA catalytic subunit. Current amplitudes are shown normalized by their steady-state values in ATP (i.e., just before ATP removal), membrane potential (Vm) was −20 to −80 mV. (B) Mean burst durations (in seconds) obtained as the time constants of single-exponential fits to the macroscopic relaxations shown in (A). Data are shown as mean ± standard error of the mean (SEM) from six to nine experiments using a logarithmic ordinate. (A, B) has been adapted from Figures 2A, B, and 3C, D from Simon and Csanády, 2023. (C, D) Cryo-EM structures of hCFTR-E1371Q (PDBID: 6msm) and zCFTR-E1372Q (PDBID: 5w81) in the OF conformation. Color coding as in (A), positions hG576/zT575 (orange), hQ1371 (black), and zQ1372 (brown) are shown in spacefill. Red dotted squares identify regions expanded in panels (E, F). (E, F) Close-up views of the regions surrounding the mutated catalytic glutamate side chains (black/brown sticks) in OF hCFTR (E) and zCFTR (F).
	Figure 3. Strong coupling between positions 576 and 1371 of hCFTR E1371Q in the bursting state.(A) Macroscopic current relaxations following ATP removal for indicated human CFTR channel mutants (color coded). Inside-out patch currents were activated by exposure of pre-phosphorylated channels to saturating ATP. Current amplitudes are shown normalized by their steady-state values in ATP (i.e., just before ATP removal). Vm was −20 to −80 mV. (B) Relaxation time constants of the currents in (A), obtained by fits to single exponentials. Data are shown as mean ± standard error of the mean (SEM) from seven to nine experiments using a logarithmic ordinate. (C) Thermodynamic mutant cycle showing mutation-induced changes in the height of the free enthalpy barrier for the B1 → IB1 transition (ΔΔG0T‡−B1, numbers on arrows; k, Boltzmann’s constant; T, absolute temperature). Each corner is represented by the mutations introduced into positions Q1371 and G576 of E1371Q-hCFTR. ΔΔGint(B1 → T‡) (purple number) is obtained as the difference between ΔΔG0T‡−B1 values along two parallel sides of the cycle. (D) Currents of last open channels after ATP removal for the indicated human CFTR constructs (color coded). Recordings were done as in panel (A), but on patches with smaller numbers of channels. Membrane potential was −80 mV. Black lines indicate the analyzed segments. (E) Intraburst equilibrium constants obtained by dwell-time analysis for the four human CFTR constructs, plotted on a logarithmic scale. Data are shown as mean ± standard error of the mean (SEM) from five to six experiments. (F) Thermodynamic mutant cycle showing mutation-induced changes in the stability of the O state relative to the Cf state (ΔΔG0O-CF, numbers on arrows; k, Boltzmann’s constant; T, absolute temperature). Each corner of the cycle is represented by the mutations introduced into positions Q1371 and G576 of E1371Q-hCFTR. ΔΔGint(Cf → O) (purple number) is obtained as the difference between ΔΔG0O-CF values along two parallel sides of the cycle.
	Figure 4—figure supplement 1. Close-up view of the region surrounding the mutated catalytic glutamate side chain (brown sticks) and D-loop residues zT575 (orange sticks) and zH576 (magenta sticks) in the cryo-EM structure of zCFTR-E1372Q, solved in the OF conformation (PDBID: 5w81).Purple dotted line illustrates suggested H-bond between the zT575 side chain and the backbone carbonyl oxygen of zA1375 (green sticks).
	Figure 4. No coupling between positions 575/576 and 1372 of zCFTR E1372Q in the bursting state.(A, D) Macroscopic current relaxations following ATP removal for indicated zCFTR channel mutants (color coded). Experiments were performed as in Figure 3A, and current amplitudes are shown normalized by their steady-state values in ATP (i.e., just before ATP removal). (B, E) Relaxation time constants of the currents in (A, D), obtained by fits to single exponentials. Data are shown as mean ± standard error of the mean (SEM) from 6 to 10 experiments using a logarithmic ordinate. (C, F) Thermodynamic mutant cycles showing mutation-induced changes in the height of the free enthalpy barrier for the B1 → IB1 transition (ΔΔG0T‡−B1, numbers on arrows; k, Boltzmann’s constant; T, absolute temperature). Each corner is represented by the mutations introduced into positions Q1372 and either T575 (C) or H576 (F) of E1372Q-zCFTR. ΔΔGint(B1 → T‡) (purple number) is obtained as the difference between ΔΔG0T‡−B1 values along two parallel sides of the cycle.
	Figure 5—figure supplement 1. Intra-NBD2 movements associated with ATP binding and tight NBD dimerization.(A) Location of positions 576, 1370, and 1371 (colored spacefill) relative to composite sites 1 and 2 in the tight hCFTR NBD dimer (PDBID: 6msm). Interacting positions 555 and 1246 (Vergani et al., 2005) are also shown in colored spacefill. (B) NBD2 structures of non-phosphorylated apo IF hCFTR (6uak; light green), non-phosphorylated ATP-bound IF hCFTR (8fzq; medium green), and phosphorylated ATP-bound OF E1371Q-hCFTR (6msm; dark green), aligned through their core subdomains. ATP (shades of yellow), and Mg2+ (shades of purple) of the ATP-bound structures are shown as sticks and spheres, respectively. Note completion of subdomain closure (curved arrow) in the OF structure. (C) Atomic models (sticks and spheres) of ATP (shades of yellow), Mg2+ (shades of purple), and residues D1370 (shades of gray) and S1251 (shades of green) from ATP-bound non-phosphorylated IF WT hCFTR (lighter tones; PDBID: 8fzq) and phosphorylated ATP-bound OF E1371Q hCFTR (darker tones; PDBID: 6msm). The core subdomain of NBD2 from 6msm was aligned with that of 8fzq in Pymol. Residue h1371 (black sticks) is shown only for the OF structure.
	Figure 5. Mutation hE1371Q strongly stabilizes, whereas hD1370N destabilizes, bursts in other non-hydrolytic backgrounds.(A) Close-up view of the site 2 interface in the OF structure of hCFTR-E1371Q (PDBID: 6msm) highlighting (in sticks) NBD1 D-loop residue hG576 (orange), and NBD2 residues hQ1371 (black), hD1370 (gray), and hK1250 (gray). ATP, yellow sticks; Mg2+, purple sphere. (B, D), Macroscopic current relaxations following ATP removal for indicated CFTR channel mutants (color coded). Experiments were performed as in Figure 3A, and current amplitudes are shown normalized by their steady-state values in ATP (i.e., just before ATP removal). (C, E), Relaxation time constants of the currents in (B, D), obtained by fits to single exponentials, displayed on a logarithmic ordinate. Data show mean ± standard error of the mean (SEM) from five to eight experiments.
	Figure 6. Coupling between bursts and ATP hydrolysis in wild-type (WT) hCFTR.Quantitative hCFTR gating cycle, color coding as in Figure 1C. Numbers represent estimated microscopic rate constants for prephosphorylated WT hCFTR channels gating in ATP at 25°C, with k−1 (red) established in the present study. Cyan arrows and numbers illustrate the fractions of bursts that are terminated by ATP hydrolysis and non-hydrolytic dissociation of composite site 2, respectively.

Aleksandrov, The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover. 2002, Pubmed

Aleksandrov, The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover. 2002, Pubmed
Basso, Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating. 2003, Pubmed , Xenbase
Bompadre, CFTR gating II: Effects of nucleotide binding on the stability of open states. 2005, Pubmed
Cai, Voltage-dependent gating of the cystic fibrosis transmembrane conductance regulator Cl- channel. 2003, Pubmed
Carson, The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity. 1995, Pubmed
Cheng, Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. 1991, Pubmed
Csanády, Thermodynamics of CFTR channel gating: a spreading conformational change initiates an irreversible gating cycle. 2006, Pubmed , Xenbase
Csanády, Strict coupling between CFTR's catalytic cycle and gating of its Cl- ion pore revealed by distributions of open channel burst durations. 2010, Pubmed , Xenbase
Csanády, Conformational changes in the catalytically inactive nucleotide-binding site of CFTR. 2013, Pubmed , Xenbase
Csanády, Catalyst-like modulation of transition states for CFTR channel opening and closing: new stimulation strategy exploits nonequilibrium gating. 2014, Pubmed , Xenbase
Csanády, STRUCTURE, GATING, AND REGULATION OF THE CFTR ANION CHANNEL. 2019, Pubmed
Dean, The human ATP-binding cassette (ABC) transporter superfamily. 2022, Pubmed
Gunderson, Conformational states of CFTR associated with channel gating: the role ATP binding and hydrolysis. 1995, Pubmed
Hohl, Crystal structure of a heterodimeric ABC transporter in its inward-facing conformation. 2012, Pubmed
Hohl, Structural basis for allosteric cross-talk between the asymmetric nucleotide binding sites of a heterodimeric ABC exporter. 2014, Pubmed
Hrycyna, Both ATP sites of human P-glycoprotein are essential but not symmetric. 1999, Pubmed
Huang, Structural basis for substrate and inhibitor recognition of human multidrug transporter MRP4. 2023, Pubmed
Janas, The ATP hydrolysis cycle of the nucleotide-binding domain of the mitochondrial ATP-binding cassette transporter Mdl1p. 2003, Pubmed
Johnson, Structural Basis of Substrate Recognition by the Multidrug Resistance Protein MRP1. 2017, Pubmed
Johnson, ATP Binding Enables Substrate Release from Multidrug Resistance Protein 1. 2018, Pubmed
Kaczmarek, Microinjection of catalytic subunit of cyclic AMP-dependent protein kinase enhances calcium action potentials of bag cell neurons in cell culture. 1980, Pubmed
Karpowich, Crystal structures of the MJ1267 ATP binding cassette reveal an induced-fit effect at the ATPase active site of an ABC transporter. 2001, Pubmed
Kim, Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation. 2018, Pubmed
Levring, CFTR function, pathology and pharmacology at single-molecule resolution. 2023, Pubmed
Li, ATPase activity of the cystic fibrosis transmembrane conductance regulator. 1996, Pubmed
Liu, Molecular Structure of the Human CFTR Ion Channel. 2017, Pubmed , Xenbase
Locher, Mechanistic diversity in ATP-binding cassette (ABC) transporters. 2016, Pubmed
Mihályi, Obligate coupling of CFTR pore opening to tight nucleotide-binding domain dimerization. 2016, Pubmed , Xenbase
Moody, Cooperative, ATP-dependent association of the nucleotide binding cassettes during the catalytic cycle of ATP-binding cassette transporters. 2002, Pubmed
Olsen, Structure of the human lipid exporter ABCB4 in a lipid environment. 2020, Pubmed
Orelle, Dynamics of alpha-helical subdomain rotation in the intact maltose ATP-binding cassette transporter. 2010, Pubmed
O'Sullivan, Cystic fibrosis. 2009, Pubmed
Powe, Mutation of Walker-A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide-binding domains. 2002, Pubmed
Procko, The mechanism of ABC transporters: general lessons from structural and functional studies of an antigenic peptide transporter. 2009, Pubmed
Rai, Conserved Asp327 of walker B motif in the N-terminal nucleotide binding domain (NBD-1) of Cdr1p of Candida albicans has acquired a new role in ATP hydrolysis. 2006, Pubmed
Ramjeesingh, Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator). 1999, Pubmed
Riordan, Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. 1989, Pubmed
Simon, Molecular pathology of the R117H cystic fibrosis mutation is explained by loss of a hydrogen bond. 2021, Pubmed , Xenbase
Simon, Optimization of CFTR gating through the evolution of its extracellular loops. 2023, Pubmed
Smith, ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. 2002, Pubmed
Song, Molecular insights into the human ABCB6 transporter. 2021, Pubmed
Sorum, Timing of CFTR pore opening and structure of its transition state. 2015, Pubmed
Sorum, Asymmetry of movements in CFTR's two ATP sites during pore opening serves their distinct functions. 2017, Pubmed , Xenbase
Szollosi, Mutant cycles at CFTR's non-canonical ATP-binding site support little interface separation during gating. 2011, Pubmed , Xenbase
Timachi, Exploring conformational equilibria of a heterodimeric ABC transporter. 2017, Pubmed
Tsai, Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel. 2010, Pubmed
Urbatsch, Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites. 1998, Pubmed
Vergani, On the mechanism of MgATP-dependent gating of CFTR Cl- channels. 2003, Pubmed , Xenbase
Vergani, CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. 2005, Pubmed
Winter, Effect of ATP concentration on CFTR Cl- channels: a kinetic analysis of channel regulation. 1994, Pubmed
Yeh, Modulation of CFTR gating by permeant ions. 2015, Pubmed
Yu, On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator. 2016, Pubmed
Zeltwanger, Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme. 1999, Pubmed
Zhang, Conformational Changes of CFTR upon Phosphorylation and ATP Binding. 2017, Pubmed
Zhang, Molecular structure of the ATP-bound, phosphorylated human CFTR. 2018, Pubmed
Zhou, High affinity ATP/ADP analogues as new tools for studying CFTR gating. 2005, Pubmed
Zhou, The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics. 2006, Pubmed